Archives: Agenda

• Drug development activity in China and key areas of enhanced activity
• Clinical trials trends and the impact of geopolitical events on outsourcing
• Is China a solution for early-phase clinical trials
• Partnering and licensing activities from China

• Transforming Protocol to Execution: How AIKA uses advanced AI to streamline protocol generation, enhance feasibility analysis, and reduce study start-up timelines.
• Data-Driven Decision Support: Leveraging real-time operational insights and predictive analytics to improve trial performance and risk mitigation.
• Scaling Clinical Operations: Practical examples of AIKA in action, from automated task orchestration to cross-functional collaboration that drives efficiency and quality.

Sponsored by EmVenio

Join us in the atrium for a drinks reception

• Why inclusive research is a business and clinical imperative
• How to continue the work in the current climate
• Increasing focus on US enrollment
• Five principles of data driven inclusive research

Sponsored by EmVenio

Join us in the atrium for a drinks reception